Design and characterization of superpotent bivalent ligands targeting oxytocin receptor dimers via a channel-like structure

Crystal structure of the β2 adrenergic receptor–Gs protein complex

Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009 · see citing works

A general method ofin vitropreparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions

Higuchi, R., Krummel, B., & Saiki, R. K. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.15.7351 · Cited by 2,416 · see citing works

Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists

Wu, B., Chien, E. Y. T., Mol, C. D., Fenalti, G., Liu, W., Katritch, V., Abagyan, R. A., Brooun, A., Wells, P. G., Bi, F. C., et al. (2010) · Science · doi:10.1126/science.1194396 · Cited by 1,785 · see citing works

Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine

Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688 · see citing works

Crystal structure of opsin in its G-protein-interacting conformation

Scheerer, P., Park, J. H., Hildebrand, P. W., Kim, Y. J., Krauß, N., Choe, H.-W., Hofmann, K. P., & Ernst, O. P. (2008) · Nature · doi:10.1038/nature07330 · Cited by 1,059 · see citing works

Oxytocin: The Great Facilitator of Life

Lee, H.-J., Macbeth, A. H., Pagani, J., & Young, W. S. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.001 · Cited by 1,037 · see citing works

Promoting social behavior with oxytocin in high-functioning autism spectrum disorders.

Andari, E., Duhamel, J.-R., Zalla, T., Herbrecht, E., Leboyer, M., & Sirigu, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910249107 · Cited by 941 · see citing works

Crystal structure of the ligand-free G-protein-coupled receptor opsin

Park, J. H., Scheerer, P., Hofmann, K. P., Choe, H., & Ernst, O. P. (2008) · Nature · doi:10.1038/nature07063 · Cited by 903 · see citing works

Structure of the human κ-opioid receptor in complex with JDTic

Wu, H., Wacker, D., Mileni, M., Katritch, V., Han, G. W., Vardy, E., Liu, W., Thompson, A. A., Huang, X., Carroll, F. I., et al. (2012) · Nature · doi:10.1038/nature10939 · Cited by 885 · see citing works

Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice

Takayanagi, Y., Yoshida, M., Bielsky, I. F., Ross, H. E., Kawamata, M., Onaka, T., Yanagisawa, T., Kimura, T., Matzuk, M. M., Young, L. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505312102 · Cited by 806 · see citing works

Oligomerization of G-protein-coupled transmitter receptors

Bouvier, M. (2001) · Nature reviews. Neuroscience · doi:10.1038/35067575 · Cited by 668 · see citing works

G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives

Ferré, S., Casadó, V., Devi, L. A., Filizola, M., Jockers, R., Lohse, M. J., Milligan, G., Pin, J., & Guitart, X. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008052 · Cited by 574 · see citing works

Cell-penetrating peptides: tools for intracellular delivery of therapeutics

Deshayes, S., Morris, M. C., Divita, G., & Heitz, F. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5109-0 · Cited by 483 · see citing works

Single-molecule analysis of fluorescently labeled G-protein–coupled receptors reveals complexes with distinct dynamics and organization

Calebiro, D., Rieken, F., Wagner, J. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205798110 · Cited by 455 · see citing works

Crystal structure of a photoactivated deprotonated intermediate of rhodopsin

Salom, D., Lodowski, D. T., Stenkamp, R. E., Trong, I. L., Golczak, M., Jastrzebska, B., Harris, T., Ballesteros, J. A., & Palczewski, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608022103 · Cited by 442 · see citing works

Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics

Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., & Guillon, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02303.x · Cited by 423 · see citing works

Real-time monitoring of receptor and G-protein interactions in living cells

Galès, C., Rebois, R. V., Hogue, M., et al. (2005) · Nature Methods · doi:10.1038/nmeth743 · Cited by 419 · see citing works

Full characterization of GPCR monomer–dimer dynamic equilibrium by single molecule imaging

Kasai, R. S., Suzuki, K. G. N., Prossnitz, E. R., Koyama‐Honda, I., Nakada, C., Fujiwara, T. K., & Kusumi, A. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201009128 · Cited by 349 · see citing works

The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial

Yatawara, C. J., Einfeld, S. L., Hickie, I. B., Davenport, T. A., & Guastella, A. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.162 · Cited by 344 · see citing works

Time-resolved FRET between GPCR ligands reveals oligomers in native tissues

Albizu, L., Cottet, M., Králíková, M., Stoev, S. B., Seyer, R., Brabet, I., Roux, T., Bazin, H., Bourrier, E., Lamarque, L., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.396 · Cited by 340 · see citing works

Oxytocin and Vasopressin V1a and V2 Receptors Form Constitutive Homo- and Heterodimers during Biosynthesis

Terrillon, S., Durroux, T., Mouillac, B., Breit, A., Ayoub, M. A., Taulan‐Cadars, M., Jockers, R., Barberis, C., & Bouvier, M. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0222 · Cited by 323 · see citing works

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients

Feifel, D., Macdonald, K., Nguyen, A., Cobb, P., Warlan, H., Galangue, B., Minassian, A., Becker, O., Cooper, J., Perry, W., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.039 · Cited by 308 · see citing works

Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series

Daniels, D. J., Lenard, N. R., Etienne, C. L., Law, P., Roerig, S. C., & Portoghese, P. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506627102 · Cited by 297 · see citing works

Spanning binding sites on allosteric proteins with polymer-linked ligand dimers

Krämer, R., & Karpen, J. W. (1998) · Nature · doi:10.1038/27227 · Cited by 279 · see citing works

International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers

Pin, J., Neubig, R. R., Bouvier, M., Devi, L. A., Filizola, M., Javitch, J. A., Lohse, M. J., Milligan, G., Palczewski, K., Parmentier, M., et al. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.1.5 · Cited by 276 · see citing works

Deciphering biased-agonism complexity reveals a new active AT1 receptor entity

Saulière, A., Bellot, M., Paris, H., Denis, C., Finana, F., Hansen, J. T., Altié, M.-F., Séguélas, M., Pathak, A., Hansen, J. L., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.961 · Cited by 208 · see citing works

Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors

Viñals, X., Moreno, E., Lanfumey, L., Cordomí, A., Pastor, A., de la Torre, R., Gasperini, P., Navarro, G., Howell, L. A., Pardo, L., et al. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002194 · Cited by 207 · see citing works

Can oxytocin treat autism?

Young, L. J., & Barrett, C. E. (2015) · Science · doi:10.1126/science.aaa8120 · Cited by 200 · see citing works

Functional Selective Oxytocin-derived Agonists Discriminate between Individual G Protein Family Subtypes

Busnelli, M., Saulière, A., Manning, M., Bouvier, M., Galès, C., & Chini, B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277178 · Cited by 195 · see citing works

Bridging the gap: bitopic ligands of G-protein-coupled receptors

Lane, J. R., Sexton, P. M., & Christopoulos, A. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.10.003 · Cited by 181 · see citing works

Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor

Chini, B., Mouillac, B., Ala, Y., Balestre, M. N., Trumpp‐Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M., Manning, M., & Jard, S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07211.x · Cited by 179 · see citing works

Evidence for the existence of dopamine d2-oxytocin receptor heteromers in the ventral and dorsal striatum with facilitatory receptor–receptor interactions

Romero-Fernandez, W., Borroto-Escuela, D. O., Agnati, L. F., & Fuxe, K. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.103 · Cited by 179 · see citing works

The Best of Both Worlds? Bitopic Orthosteric/Allosteric Ligands of G Protein–Coupled Receptors

Valant, C., Lane, J. R., Sexton, P. M., & Christopoulos, A. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134514 · Cited by 169 · see citing works

Oxytocic plant cyclotides as templates for peptide G protein-coupled receptor ligand design

Koehbach, J., O’Brien, M., Muttenthaler, M., Miazzo, M., Akcan, M., Elliott, A. G., Daly, N. L., Harvey, P. J., Arrowsmith, S., Gunasekera, S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311183110 · Cited by 155 · see citing works

Allosteric interactions between agonists and antagonists within the adenosine A 2A receptor-dopamine D 2 receptor heterotetramer

Bonaventura, J., Navarro, G., Casadó-Anguera, V., Azdad, K., Rea, W. P., Moreno, E., Brugarolas, M., Mallol, J., Canela, E. I., Lluı́s, C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507704112 · Cited by 149 · see citing works

Single Molecule Analysis of Functionally Asymmetric G Protein-coupled Receptor (GPCR) Oligomers Reveals Diverse Spatial and Structural Assemblies

Jonas, K., Fanelli, F., Huhtaniemi, I. T., & Hanyaloglu, A. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.622498 · Cited by 125 · see citing works

BRET biosensors to study GPCR biology, pharmacology, and signal transduction

Salahpour, A. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00105 · Cited by 122 · see citing works

Functional Selectivity of Allosteric Interactions within G Protein–Coupled Receptor Oligomers: The Dopamine D1-D3 Receptor Heterotetramer

Guitart, X., Navarro, G., Moreno, E., Yano, H., Cai, N.-S., Sánchez‐Soto, M., Barodia, S. K., Naidu, Y. T., Mallol, J., Cortés, A., et al. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.093096 · Cited by 122 · see citing works

Neurohypophyseal hormones manipulation modulate social and anxiety-related behavior in zebrafish

Braida, D., Donzelli, A., Martucci, R., Capurro, V., Busnelli, M., Chini, B., & Sala, M. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2482-2 · Cited by 116 · see citing works

Class A G-Protein-Coupled Receptor (GPCR) Dimers and Bivalent Ligands

Hiller, C., Kühhorn, J., & Gmeiner, P. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4004335 · Cited by 116 · see citing works

Oxytocin and Autism: A Systematic Review of Randomized Controlled Trials

Preti, A., Melis, M., Siddi, S., Vellante, M., Doneddu, G., & Fadda, R. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0040 · Cited by 114 · see citing works

Probing the Existence of G Protein-Coupled Receptor Dimers by Positive and Negative Ligand-Dependent Cooperative Binding

Albizu, L., Balestre, M., Breton, C., Pin, J., Manning, M., Mouillac, B., Barberis, C., & Durroux, T. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025684 · Cited by 108 · see citing works

Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors

Busnelli, M., Bulgheroni, E., Manning, M., Kleinau, G., & Chini, B. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.202994 · Cited by 102 · see citing works

Activation Mechanism of Human Oxytocin Receptor: A Combined Study of Experimental and Computer-Simulated Mutagenesis

Fanelli, F., Barbier, P., Zanchetta, D., Benedetti, P. G. D., & Chini, B. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.214 · Cited by 102 · see citing works

Design Strategies for Bivalent Ligands Targeting GPCRs

Shonberg, J., Scammells, P. J., & Capuano, B. (2011) · ChemMedChem · doi:10.1002/cmdc.201100101 · Cited by 99 · see citing works

Mice Heterozygous for the Oxytocin Receptor Gene (Oxtr+/−) Show Impaired Social Behaviour but not Increased Aggression or Cognitive Inflexibility: Evidence of a Selective Haploinsufficiency Gene Effect

Sala, M., Braida, D., Donzelli, A., Martucci, R., Busnelli, M., Bulgheroni, E., Rubino, T., Parolaro, D., Nishimori, K., & Chini, B. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02385.x · Cited by 99 · see citing works

Assessing the Relative Stability of Dimer Interfaces in G Protein-Coupled Receptors

Johnston, J. M., Wang, H., Provasi, D., & Filizola, M. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002649 · Cited by 98 · see citing works

Revealing G‐protein‐coupled receptor oligomerization at the single‐molecule level through a nanoscopic lens: methods, dynamics and biological function

Scarselli, M., Annibale, P., McCormick, P. J., Kolachalam, S., Aringhieri, S., Rađenović, A., Corsini, G. U., & Maggio, R. (2015) · FEBS Journal · doi:10.1111/febs.13577 · Cited by 79 · see citing works

Disruption of Rhodopsin Dimerization with Synthetic Peptides Targeting an Interaction Interface

Jastrzębska, B., Chen, Y., Orban, T., Jin, H., Hofmann, L., & Palczewski, K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.662684 · Cited by 78 · see citing works

Orexin–Corticotropin-Releasing Factor Receptor Heteromers in the Ventral Tegmental Area as Targets for Cocaine

Navarro, G., Quiroz, C., Moreno‐Delgado, D., Sierakowiak, A., McDowell, K. A., Moreno, E., Rea, W. P., Cai, N.-S., Aguinaga, D., Howell, L. A., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4364-14.2015 · Cited by 75 · see citing works

Lower efficacy: interaction with an inhibitory receptor or partial agonism?

Rovati, G. E., & NICOSIA, S. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90073-6 · Cited by 73 · see citing works

Inhibition of Inflammatory and Neuropathic Pain by Targeting a Mu Opioid Receptor/Chemokine Receptor5 Heteromer (MOR-CCR5)

Akgün, E., Javed, M. I., Lunzer, M. M., Powers, M. D., Sham, Y. Y., Watanabe, Y., & Portoghese, P. S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01245 · Cited by 59 · see citing works

Transmembrane peptides as unique tools to demonstrate the in vivo action of a cross‐class GPCR heterocomplex

Lee, L. T. O., Ng, S., Chu, J., Sekar, R., Harikumar, K. G., Miller, L. J., & Chow, B. (2014) · The FASEB Journal · doi:10.1096/fj.13-246868 · Cited by 52 · see citing works

Past, present and future of vasopressin and oxytocin receptor oligomers, prototypical GPCR models to study dimerization processes

Cottet, M., Albizu, L., Perkovska, S., Jean‐Alphonse, F., Rahmeh, R., Orcel, H., Méjean, C., Granier, S., Mendre, C., & Mouillac, B. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.10.003 · Cited by 49 · see citing works

Synthesis of Specific Bivalent Probes That Functionally Interact with 5-HT4 Receptor Dimers

Russo, O., Berthouze, M., Giner, M., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070552t · Cited by 46 · see citing works

Targeting putative mu opioid/metabotropic glutamate receptor-5 heteromers produces potent antinociception in a chronic murine bone cancer model

Smeester, B. A., Lunzer, M. M., Akgün, E., et al. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.09.008 · Cited by 45 · see citing works

Design and Synthesis of Specific Probes for Human 5-HT4 Receptor Dimerization Studies

Soulier, J., Russo, O., Giner, M., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050234z · Cited by 44 · see citing works

An in Vitro and in Vivo Investigation of Bivalent Ligands That Display Preferential Binding and Functional Activity for Different Melanocortin Receptor Homodimers

Lensing, C. J., Freeman, K. T., Schnell, S. M., Adank, D. N., Speth, R. C., & Haskell‐Luevano, C. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01894 · Cited by 44 · see citing works

Allosteric interactions between the oxytocin receptor and the β2-adrenergic receptor in the modulation of ERK1/2 activation are mediated by heterodimerization

Wrzal, P. K., Devost, D., Pétrin, D., Goupil, E., Iorio‐Morin, C., Laporte, S. A., Zingg, H. H., & Hébert, T. E. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.09.020 · Cited by 42 · see citing works

The Bivalent Ligand Approach Leads to Highly Potent and Selective Acylguanidine-Type Histamine H2Receptor Agonists

Birnkammer, T., Spickenreither, A., Brunskole, I., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201128q · Cited by 41 · see citing works

Functional interactions between the oxytocin receptor and the β2-adrenergic receptor: Implications for ERK1/2 activation in human myometrial cells

Wrzal, P. K., Goupil, E., Laporte, S. A., et al. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.09.019 · Cited by 37 · see citing works

Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue

Chini, B., Chinol, M., Cassoni, P., Papi, S., Reversi, A., Areces, L. B., Marrocco, T., Paganelli, G., Manning, M., & Bussolati, G. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601189 · Cited by 36 · see citing works

Influence of Spacer–Receptor Interactions on the Stability of Bivalent Ligand–Receptor Complexes

Numata, J., Juneja, A., Diestler, D. J., & Knapp, E. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp211383s · Cited by 29 · see citing works

Synthesis and binding affinity of novel mono- and bivalent morphinan ligands for κ, μ, and δ opioid receptors

Zhang, B., Zhang, T., Sromek, A. W., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.052 · Cited by 24 · see citing works

Univalent and Bivalent Ligands of Butorphan: Characteristics of the Linking Chain Determine the Affinity and Potency of Such Opioid Ligands

Decker, M. W., Fulton, B. S., Zhang, B., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900379p · Cited by 23 · see citing works

Synthesis and biological evaluation of bivalent cannabinoid receptor ligands based on hCB2R selective benzimidazoles reveal unexpected intrinsic properties

Nimczick, M., Pemp, D., Darras, F. H., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.06.008 · Cited by 22 · see citing works

A new class of potent bradykinin antagonist dimers

Gera, L., Stewart, J. M., Whalley, E. T., Burkard, M., & Zuzack, J. S. (1996) · Immunopharmacology · doi:10.1016/0162-3109(96)00099-9 · Cited by 17 · see citing works

Superactive mutants of thromboxane prostanoid receptor: functional and computational analysis of an active form alternative to constitutively active mutants

Ambrosio, M., Fanelli, F., Brocchetti, S., Raimondi, F., Mauri, M., Rovati, G. E., & Capra, V. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0368-9 · Cited by 17 · see citing works

The oxytocin receptor: from intracellular signaling to behavior

Jurek, B., & Neumann, I. D. (2018) · Physiological Reviews · doi:10.1152/physrev.00031.2017 · Cited by 999 · see citing works

Cross-talk among oxytocin and arginine-vasopressin receptors: Relevance for basic and clinical studies of the brain and periphery

Song, Z., & Albers, H. E. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.10.004 · Cited by 244 · see citing works

The action radius of oxytocin release in the mammalian CNS: from single vesicles to behavior

Chini, B., Verhage, M., & Grinevich, V. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.08.005 · Cited by 141 · see citing works

The oxytocin receptor represents a key hub in the GPCR heteroreceptor network: Potential relevance for brain and behavior

Borroto-Escuela, D. O., Cuesta-Marti, C., Lopez-Salas, A., Chruścicka-Smaga, B., Crespo-Ramírez, M., Tesoro-Cruz, E., Palacios-Lagunas, D. A., Perez de la Mora, M., Schellekens, H., & Fuxe, K. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1055344 · Cited by 38 · see citing works

Loss of myometrial oxytocin receptors during oxytocin-induced and oxytocin-augmented labour

Phaneuf, S., Rodriguez Linares, B., TambyRaja, R., MacKenzie, I., & Lopez Bernal, A. (2000) · Reproduction · doi:10.1530/jrf.0.1200091 · Cited by 216 · see citing works

Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin

Gimpl, G., Postina, R., Fahrenholz, F., et al. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.01.010 · Cited by 37 · see citing works

Progesterone metabolite and spontaneous myometrial contractions in vitro

Thornton, S., Terzidou, V., Clark, A., & Blanks, A. M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05247-7 · Cited by 42 · see citing works

The role of oxytocin in parturition

BLANKS, A. (2003) · BJOG: An International Journal of Obstetrics and Gynaecology · doi:10.1016/s1470-0328(03)00024-7 · Cited by 296 · see citing works

Oxytocin receptors and contractile response of the myometrium after long term infusion of prostaglandin F2α, indomethacin, oxytocin and an oxytocin antagonist in rats

Engstrøm, T., Atke, A., & Vilhardt, H. (1988) · Regulatory Peptides · doi:10.1016/0167-0115(88)90058-4 · Cited by 25 · see citing works